1 / 19

Sleep case #1

Sleep case #1. Case. 64 yo male smoker with hyperlipidemia BMI 28 Prev diagnosis of OSA Referred for daytime sleepiness. Prev results. 12/2006 sleep study: AHI 15.8 5/2007 PAP titration – good response to CPAP 6cm, 54 mins of sleep including REM-supine seen

greenehelen
Download Presentation

Sleep case #1

An Image/Link below is provided (as is) to download presentation Download Policy: Content on the Website is provided to you AS IS for your information and personal use and may not be sold / licensed / shared on other websites without getting consent from its author. Content is provided to you AS IS for your information and personal use only. Download presentation by click this link. While downloading, if for some reason you are not able to download a presentation, the publisher may have deleted the file from their server. During download, if you can't get a presentation, the file might be deleted by the publisher.

E N D

Presentation Transcript

  1. Sleep case #1

  2. Case • 64 yo male smoker with hyperlipidemia • BMI 28 • Prev diagnosis of OSA • Referred for daytime sleepiness

  3. Prev results • 12/2006 sleep study: AHI 15.8 • 5/2007 PAP titration – good response to CPAP 6cm, 54 mins of sleep including REM-supine seen • Did not get home CPAP at that time • Summer 2012: Another provider started him on CPAP based on 2006/2007 study results and ordered PSG which was performed in 10/2012

  4. Visit Jan 2013 • Started on CPAP over the summer 2012 • Using it nightly and has met compliance with 4.5h ave use • Feels he is sleeping better • No improvement in daytime sleepiness (ESS 18/24) • Irregular schedule • Difficulty falling and staying asleep • Estimates he gets 3-6 hours sleep/night • Works as a school bus driver

  5. Assessment? Next steps? Any special considerations in this patient?

  6. 10/2012 sleep study

  7. Sleep study results 10/2012 • TIB 424 min TST 344 min WASO 67 min • Sleep efficiency 81% • Sleep latency 11 mins, REM latency 17.5 mins • Sleep stages: 4.1% N1, 70.5% N2, 0% N3, 25.4% REM • Position: 65 min supine, 278 min on left • AHI 5.2 overall, supine 10.9, REM 16.5, supine REM 57 • Sat >90% entire study

  8. Impression?Next steps?

  9. PSG on CPAP/MSLT performed

  10. PSG/MSLT results • PSG: TST 382 mins, efficiency 83%, CPAP titrated from 6cm to 8cm. AHI 0. • MSLT • Nap 1: SL 1 min, REM latency 11 min • Nap 2: SL 1 min, no REM periods • Nap 3, SL 1 min, no REM periods • Nap 4: SL 4 min, no REM periods • Nap 5: SL 1 min, REM latency 5 min • Mean SL: 1.8 min, 2 SOREMs

  11. Diagnosis? Treatment?

  12. Narcolepsy • #2 cause of daytime sleepiness (#1 = OSA) • Onset typically teens and early 20’s, but can be after age 40 • NL with and without cataplexy • Pathology of NL + cataplexy (~70%): loss of neurons that produce orexin (a.k.a. hypocretin) • Wake-promoting • Stabilize wake/sleep • Inhibit REM • NL without cataplexy less well-understood • Possibly less extensive loss of orexin

  13. Symptoms of narcolepsy • EDS • Fragmented sleep • REM-related phenomena intrude into wakefulness • (Cataplexy) • Hypnagogic hallucinations • Sleep paralysis

  14. Multiple Sleep Latency Test • PSG the night before • 5 opportunities to nap, every 2 hours • 20 minutes to fall asleep • If fall asleep, allow 15 minutes of sleep • Data obtained: • Number of naps in which sleep is obtained • Mean sleep latency • If no sleep, 20 minutes for that nap • Number of SOREMs

  15. Diagnosis of Narcolepsy • EDS + cataplexy • Narcolepsy without cataplexy – definitive diagnosis • Mean SL < 8 mins • ≥ 2 SOREMs

  16. Treatment of Narcolepsy • Wake-promoting agents • Modafinil/armodafinil (provigil/nuvigil) • Likely increase dopa signaling • Amphetamines • e.g Methylphenidate • REM-suppressing drugs • Increase norepi and serotonin • Venlafaxine • Fluoxetine • Tricyclics • Sodium oxybate at bedtime (analog of GHB, GABA analog)

More Related